Respiratory Infections News

The FDA this week approved the antibiotic Zevtera for the treatment of three bacterial infections 17 years after it was first submitted to the agency.

Receipt of an updated COVID-19 vaccine lowered the risk for hospitalization among immunocompromised people by around one-third, according to a study.

A person in Texas tested positive for highly pathogenic avian influenza after having exposure to dairy cattle that are presumed to also be infected with the virus, health officials reported.

Since the beginning of the COVID-19 pandemic, there has been a “significant decrease” in the risk for post-acute sequelae of COVID-19 among patients with rheumatic diseases, according to data published in The Journal of Rheumatology.

A GSK respiratory syncytial virus vaccine candidate was effective but trials saw a higher incidence in preterm birth, according to research published in the New England Journal of Medicine.

Artificial intelligence has emerged as a potentially important tool for patient care, including in infectious diseases.

Moderna announced positive interim results from a phase 3 trial of its next-generation COVID-19 vaccine, which the company said will help pave the way for its combination shot against COVID-19 and influenza.

The role of serologic testing for SARS-CoV-2 has evolved during the pandemic, leading the Infectious Diseases Society of America to update its guidance.

Although the United States has one of the lowest tuberculosis incidence rates in the world, TB cases increased in the U.S. in 2023 among nearly all demographics, data from an MMWR report showed.

Among patients with tuberculosis in high-incidence countries, more than 80% did not report persistent cough and more than 60% did not report cough all together, according to results published in The Lancet Infectious Diseases.